AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 7.05 |
Market Cap | 670.85M |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | -3.14 |
PE Ratio (ttm) | -5.59 |
Forward PE | n/a |
Analyst | Strong Buy |
Ask | 27.84 |
Volume | 166,205 |
Avg. Volume (20D) | 263,091 |
Open | 17.46 |
Previous Close | 17.37 |
Day's Range | 17.31 - 17.61 |
52-Week Range | 12.08 - 20.73 |
Beta | undefined |
About OFIX
Orthofix Medical Inc. operates as a medical device and biologics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion, as well as used as a therapeutic treatment for non-spinal and append...
Analyst Forecast
According to 3 analyst ratings, the average rating for OFIX stock is "Strong Buy." The 12-month stock price forecast is $23, which is an increase of 31.02% from the latest price.
Next Earnings Release
Analysts project revenue of $213.30M, reflecting a 6.43% YoY growth and earnings per share of 0.07, making a -111.86% decrease YoY.